Latest updates
Update history: LCD and article updates
View the most recent updates for our LCDs and articles. A final LCD has become effective.
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
Part B billing, payment methodology and documentation requirements for non-sheet skin substitute products
This article outlines billing, payment methodology, and documentation requirements for non-sheet skin substitute products. It clarifies that the appropriate application codes must be submitted on the…
Current processing issues
An update was made to a Part B issue reflecting pending claims are now finalized and payments started with the May 11 cycle.
MLN Connects for May 14, 2026
This edition includes information on National Mental Health Awareness Month, remote patient monitoring, the hantavirus cluster, and more.
MLN Connects for May 14, 2026
This edition includes information on National Mental Health Awareness Month, remote patient monitoring, the hantavirus cluster, and more.
Form 480.6A -- "Informativa de Ingreso"
As a MAC, First Coast does not provide the "Informativa de Ingreso 480.6A" or an equivalent document disclosing the provider's annual reimbursement to providers in Puerto Rico or the U.S. Virgin…
Form 480.6A -- "Informativa de Ingreso"
As a MAC, First Coast does not provide the "Informativa de Ingreso 480.6A" or an equivalent document disclosing the provider's annual reimbursement to providers in Puerto Rico or the U.S. Virgin…
Process for supplying invoice amount on certain HCPCS codes - avoid rejected claims
The supply codes list has been updated.